NNG fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
NanoGroup SA engages in the medical research and development. It develops diagnostic, therapeutic and rehabilitation tools for oncology patients. The company's projects include Nanovelos, NanoSanguis and NanoTHEA. NanoGroup was founded by Tomasz Adam Ciach on December 2, 2016 and is headquartered Warsaw, Poland.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
NNG does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company